Juntendo University, Tokyo, established in 1838.

  1. Home
  2. Research
  3. Department of Ophthalmology

Department of Ophthalmology

 Introduction   Staff   Research   Education   Achievements   Recruitment   Links
 Japanese     Index

Achievements

｜2021｜2020｜2019｜2018｜2017｜2016｜2015｜2014｜2013｜2012｜2011｜2010｜
｜2009｜2008｜2007｜2006｜2005｜2004｜

2021

【Original Articles】
  1. Yasudo H, Ando T, Maehara A, Ando T, Izawa K, Tanabe A, Kaitani A, Nomura S, Seki M, Yoshida K, Oda H, Okamoto Y, Wang H, Kamei A, Kojima M, Kimura M, Uchida K, Nakano N, Kaneko J, Ebihara N, Hasegawa K, Shimizu T, Takita J, Ogawa H, Okumura K, Ogawa S, Tamura N, Kitaura J: A possible association between a nucleotide-binding domain lrr-containing protein family pyd-containing protein 1 mutation and an autoinflammatory disease involving liver cirrhosis. Hepatology, 2021; 74(4): 2296-2299. (IF: 17.425)
  2. Inomata T, Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Symptom-based stratification for hay fever: A crowdsourced study using the smartphone application AllerSearch. Allergy, 2021; 76(12): 3820-3824. (IF: 13.146)
  3. Inomata T, Nakamura M, Sung J, Midorikawa-Inomata A, Iwagami M, Fujio K, Akasaki Y, Okumura Y, Fujimoto K, Eguchi A, Miura M, Nagino K, Shokirova H, Zhu J, Kuwahara M, Hirosawa K, Dana R, Murakami A: Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study. NPJ Digital Medicine, 2021; 4(1): 171. (IF: 11.653)
  4. Toyoshima S, Sakamoto-Sasaki T, Kurosawa Y, Hayama K, Matsuda A, Watanabe Y, Terui Y, Gon Y, Matsumoto K, Okayama Y. miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells. J Allergy Clin Immunol. 2021, 147:1878-1891. (IF: 10.793)
  5. Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C: The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells, 2021; 10(4). (IF: 6.600)
  6. Inomata T, Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch. Allergol Int, 2022(in press).(IF: 5.836)
  7. Fukase S, Ando T, Matsuzawa M, Kimura M, Sone Y, Izawa K, Kaitani A, Kamei A, Kojima M, Nakano N, Maeda K, Shimizu T, Ogawa H, Okumura K, Nishiyama M, Murakami A, Ebihara N, Kitaura J: Pollen shells and soluble factors play non-redundant roles in the development of allergic conjunctivitis in mice. Ocul Surf, 2021; 22: 152-162. (IF: 5.033)
  8. Zhu J, Inomata T, Fujimoto K, Uchida K, Fujio K, Nagino K, Miura M, Negishi N, Okumura Y, Akasaki Y, Hirosawa K, Kuwahara M, Eguchi A, Shokirova H, Yanagawa A, Midorikawa-Inomata A, Murakami A: Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice. Invest Ophthalmol Vis Sci, 2021; 62(7): 3. (IF: 4.799)
  9. Yamada M, Hiratsuka Y: Detection of glaucoma and other vision-threatening ocular diseases in the population recruited at specific health checkups in Japan. Clin Epidemiol, 2020; 12: 1381-1388. (IF: 4.79)
  10. Ono K, Murakami A, Haishima Y: A web-based survey of contact lens-related adverse events among the Japanese female population. 　Sci Rep 2021 Published online Aug 05; 11(1): 15939 (IF: 4.38)
  11. Kudo D, Hiratsuka Y, Nakamura M, Uchida Y, Ono S, Murakami A.Optimal methods for estimating sports vision in kendo athletes. Sci Rep. 2021 Jan 11;11(1):315. doi: 10.1038/s41598-020-79534-1.PMID: 33431981. (IF: 4.38)
  12. Hirakata T, Hiratsuka Y, Yamamoto S, Kanbayashi K, Kobayashi H, Murakami A: Risk factors for macular pucker after rhegmatogenous retinal detachment surgery. Sci Rep, 2021 Sep 14; 11(1): 18276. (IF: 4.38)
  13. Shokirova H, Inomata T, Saitoh T, Zhu J, Fujio K, Okumura Y, Yanagawa A, Fujimoto K, Sung J, Eguchi A, Miura M, Nagino K, Hirosawa K, Kuwahara M, Akasaki Y, Nagase H, Murakami A. Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation. Sci Rep, 2021; 11(1): 8647. (IF: 4.38)
  14. Zhu J, ○Inomata T, Di Zazzo A, Kitazawa K, Okumura Y, Coassin M, Surico PL, Fujio K, Yanagawa A, Miura M, Akasaki Y, Fujimoto K, Nagino K, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Huang T, Shokirova H, Eguchi A, Murakami A: Role of immune cell diversity and heterogeneity in corneal graft survival: a systematic review and meta-analysis. J Clin Med, 2021; 10(20): 4667. (IF: 4.242)
  15. Takesue A, Hiratsuka Y, Inoue A, Kondo K, Aida J: Is social participation associated with good self-rated health among visually impaired older adults? : The JAGES cross-sectional study. BMC geriatrics, 2021. Oct 23; 21(1): 592. doi: 10.1186/s12877 -021-02554-7. (IF: 3.921)
  16. Sakanishi Y, Morita S, Mashimo K, Tamaki K, Ebihara N: Subfoveal choroidal thickness and treatment outcomes of intravitreal aflibercept for branch retinal vein occlusion. Life (Basel), 2021 Jun 17; 11(6): 572. doi: 10.3390/life11060572. (IF: 3.817)
  17. Usui-Ouchi A, Tamaki A, Sakanishi Y, Tamaki K, Mashimo K, Sakuma T, Ebihara N: Factors affecting a short-term response to anti-vegf therapy in diabetic macular edema, Life (Basel), 2021 Jan 25; 11(2): 83. doi: 10.3390/life11020083. (IF: 3.817)
  18. Hirakata T, Huang T, Hiratsuka Y, Yamamoto S, Inoue A, Murakami A: Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo center. PLoS One. 2021; 16(12): e0261779. (IF: 3.240)
  19. Chiba-Mayumi M, Hirakata T, Yamaguchi M, Murakami A: Infliximab recovers central cone dysfunction with normal fundus in a patient with ulcerative colitis. Am J Ophthalmol Case Rep, 2021; 25: 101244. (IF: 3.240)
  20. Sakanishi Y, Tamaki K, Mashimo K, Sakuma T, Ebihara N: Relationship between Recurrence of Macular Edema Due to Branch Retinal Vein Occlusion and Changes in Choroidal Thickness. Ophthalmic Res, 2021; 64(3): 363-368. (IF: 2.892)
  21. Asaoka S, Kasuga T, Matsunaga T, Hayashi Y, Asada Y, Iwamoto S, Hirakata T, Honda R, Obazawa H, Sasaki H, Ohta T, Matsuda A.Operative Complications of Glaucoma Drainage Implant Tube Insertion Through the Sulcus for Pseudophakic Eye. J Glaucoma, 2021; 30(4): e169-e174. (IF: 2.503)
  22. Hiratsuka Y, Ono K, Takesue A, Sadamatsu Y, Yamada M, Otani K, Sekiguchi M, Konno S, Fukuhara S, Murakami A; The prevalence of uncorrected refractive error in Japan: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study. Jpn J Ophthalmol, 2022 (in press). (IF: 2.447)
  23. Sakanishi Y, Yasuda K, Morita S, Mashimo K, Tamaki K, Sakuma T, Ebihara N: Twenty-four-month results of intravitreal aflibercept for macular edema due to branch retinal vein occlusion. Jpn J Ophthalmol, 2021; 65(1): 63-68. (IF: 2.447)
  24. Mashimo K, Usui-Ouchi A, Ito Y, Wakasa-Arai R, Yokoi N, Kawasaki S, Murakami A, Matsuda A, Ebihara N: Role of oncostatin M in the pathogenesis of vernalkeratoconjunctivitis: focus on tissue remodeling. Jpn J Ophthalmol, 2021; 65(1): 144-153. (IF: 2.447)
  25. Hirakata T, Fujinami K, Saito W, Kanda A, Hirakata A, Ishida S, Murakami A, Tsunoda K, Miyake Y: Acute unilateral inner retinal dysfunction with photophobia: importance of electrodiagnosis. Jpn J Ophthalmol, 2021; 65(1): 42-53. (IF: 2.447)
  26. Sadamatsu Y, Ono K, Hiratsuka Y, Takesue A, Tano T, Yamada M, Otani K, Sekiguchi M, Konno S, Kikuchi S, Fukuhara S, Murakami A: Prevalence and factors associated with uncorrected presbyopia in a rural population of Japan: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study. Jpn J Ophthalmol, 2021 Sep; 65(5): 724-730. (IF: 2.447)
  27. Tamura H, Akune Y, Hiratsuka Y, Kawasaki R, Kido A, Miyake M, Goto R, Yamada M: Real-world effectiveness of screening programs for age-related macular degeneration: amended Japanese specific health checkups and augmented screening programs with OCT or AI. Jpn J Ophthalmol, (in press) . (IF: 2.447)
  28. Eguchi A, Inomata T, Nakamura M, Nagino K, Iwagami M, Sung J, Midorikawa-Inomata A, Okumura Y, Fujio K, Fujimoto K, Miura M, Akasaki Y, Shokirova H, Hirosawa K, Kuwahara M, Zhu J, Dana R, Murakami A, Kobayashi H: Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application. Jpn J Ophthalmology, 2021; 65(2): 271-281. (IF: 2.447)
  29. Takai Y, Sakanishi Y, Okamoto M, Ebihara N: Sympathetic ophthalmia after 27-G pars plana vitrectomy. BMC Ophthalmol, 2021 May 2; 21(1): 195. doi: 10.1186/s12886- 021-01961-z. (IF: 2.209)
  30. Ono K, Sakemi F, Marumoto T: Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma. Int Ophthalmol, 2021; (41): 605-611. (IF: 2.031)
  31. Watanabe S, Hamanaka T, Sakurai T, Kobayashi K, Ishida N, Ebihara N: Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis. Int Ophthalmol, 2021; 41(2): 509-517. (IF: 2.031)
  32. Shigeyasu C, Yamada M, Fukuda M, Koh S, Suzuki T, Toshida H, Oie Y, Nejima R, Eguchi H, Kawasaki R, Nishida K; Research Group of Severe Contact Lens- associated Ocular Complications.　Severe Ocular Complications Associated With Wearing of Contact Lens in Japan. Eye Contact Lens. (in press) . (IF: 2.018)
  33. Umeya R, Yoshida Y, Ono K: Impact of retinal vein occlusion on cardiovascular events in elderly Japanese patients. Medicine (Baltimore), 2021 Dec 30; 100(52): e28424. (IF: 1.889)
  34. Umeya U, Ono K, Kasuga T: Visual acuity after intravitreal ranibizumab with and without laseddr therapy in the treatment of macular edema due to branch retinal vein occlusion: a 12-month retrospective analysis. Int J Ophthalmol, 2021; 14(10): 1565-1570. (IF: 1.779)
  35. Fujimoto K, Uchida K, Yin E, Zhu J, Kojima Y, Uchiyama M, Yamamoto Y, Bashuda H, Matsumoto R, Tokushige K, Harada M, Inomata T, Kitaura J, Murakami A, Okumura K, Takeda K. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation. Transpl Immunol, 2021; 67: 101405. (IF: 1.708)
  36. Yoshida Y, Ono K, Tano T, Hiratsuka Y, Otani K, Sekiguchi M, Konno S, Kikuchi S, Yamada M, Fukuhara S, Murakami A: Corneal eccentricity in a rural japanese population: the locomotive syndrome and health outcome in aizu cohort study (LOHAS). Ophthalmic Epidemiol, 2021 Published online Aug 24; 1-6. (IF: 1.648)
  37. Hiratsuka Y, Michihata N, Jo T, Matsui H, Inoue A, Murakami A, Fushimi K, Yasunaga H: Improvement in activities of daily living after cataract surgery in the very old. Annals of Clinical Epidemiology, 2021; 3(4): 1-7.
  38. Widjaja SA, Hiratsuka Y, Ono K, Yustiarini I, Nurwasis N, Murakami A: Ocular trauma trends in indonesia: poor initial uncorrected visual acuity associated with mechanism of injury. Open Access Maced J Med Sci, 2021 Aug 29; 9(B): 903-908.
To Page Top

2020

【Original Articles】
  1. Inomata T, Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y, Iwata N, Fujio K, Hiratsuka Y, Hori S, Tsubota K, Dana R, Murakami A: Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application. Ocul Surf. 2020; 18(2): 312-319. doi: 10.1016/j.jtos.2020.02.007, Epub 2020 Feb 27. (IF:12.336)
  2. Usui-Ouchi A, Aguilar E, Murinello S, Prins M, Gantner ML, Wright PE, Berlow RB, Friedlander M：An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization. Proc Natl Acad Sci U S A, 2020;117(45):28297-28306. (IF 9.35)
  3. Suzumura A, Kaneko H, Funahashi Y, Takayama K, Nagaya M, Ito S, Okuno T, Hirakata T, Nonobe N, Kataoka K, Shimizu H, Namba R, Yamada K, Ye F, Ozawa Y, Yokomizo T, Terasaki H. n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Müller BDNF in Diabetic Retinopathy. Diabetes. 2020 Apr;69(4):724-735. （IF: 7.772）
  4. Fukuda K, Ebihara N, Kishimoto T, Fukushima A: Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis. J Allergy Clin Immunol Pract. 2020; 8(3): 1152-1155. doi: 10.1016/j.jaip.2019.10.011, Epub 2019 Oct 31.（IF: 7.574）
  5. Izawa K, Kaitani A, Ando T, Maehara A, Nagamine M, Yamada H, Ando T, Ide T, Matsuzawa M, Okamoto Y, Yin E, Fukase S, Wang H, Kamei A, Uchida S, Maeda K, Nakano N, Uchida K, Tamura N, Ikeda K, Ebihara N, Shimizu T, Voehringer D, Roers A, Ogawa H, Okumura K, Kitaura J: Differential Lipid Recognition by Mouse versus Human CD300f, Inhibiting Passive Cutaneous Anaphylaxis, Depends on a Single Amino Acid Substitution in its Immunoglobulin-Like Domain. J Invest Dermatol. 2020; 140(3):710-713.e3. doi: 10.1016/j.jid.2019.08.439, Epub 2019 Aug 30.（IF: 7.143）
  6. Usui-Ouchi A, Usui Y, Kurihara T, Aguilar E, Dorrell MI, Ideguchi Y, Sakimoto S, Bravo S, Friedlander M：Retinal microglia are critical for subretinal neovascular formation. JCI Insight, 2020;5(12):e137317. （IF: 6.205）
  7. Inomata T, Iwagami　M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y,Eguchi A, Iwata Nanami, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmol. 2020; 138(1): 58-68. doi: 10.1001/jamaophthalmol.2019.4815（IF: 6.198）
  8. Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Sung J, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Fujio K, Nagino K, Hori S, Tsubota K, Dana R, Murakami A: Stratification of Individual Symptoms of Contact Lens-Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study. J Med Internet Res. 2020; 22(6): e18996. doi: 10.2196/18996（IF: 5.034）
  9. Miyazaki D, Fukagawa K, Okamoto S, Fukushima A, Uchio E, Ebihara N, Shoji J, Namba K, Shimizu Y: Epidemiological aspects of allergic conjunctivitis. Allergol Int, 2020; 69(4): 487-495. doi: 10.1016/j.alit.2020.06.004, Epub 2020 Jul 9.（IF: 4.806）
  10. Hosoda T, Uehara Y, Kasuga T, Naito T.　An HIV-infected patient with acute retinal necrosis as immune reconstitution inflammatory syndrome due to varicella-zoster virus.AIDS. 2020, 34(5): 795-796. （IF: 4.534）
  11. Inomata T, Fujimoto K, Okumura Y, Zhu J, Fujio K, Shokirova H, Miura M, Okano M, Funaki T, Sung J, Negishi N, Murakami A: Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival. Sci Rep. 2020;10(1):19817. doi: 10.1038/　s41598-020-76882-w. （IF: 3.998）
  12. Adachi K, Asada Y, Hirakata T, Onoue M, Iwamoto S, Kasuga T, Matsuda A: Alteration of gene expression in mice after glaucoma filtration surgery, Sci Rep. 2020; 10(1): 15036. doi: 10.1038/s41598-020-72036-0. （IF: 3.998）
  13. Yang L, Fujinami K, Ueno S, Kuniyoshi K, Hayashi T, Kondo M, Mizota A, Naoi N, Shinoda K, Kameya S, Fujinami-Yokokawa Y, Liu X, Arno G, Pontikos N, Kominami T, Terasaki H, Sakuramoto H, Katagiri S, Mizobuchi K, Nakamura N, Mawatari G, Kurihara T, Tsubota K, Miyake Y, Yoshitake K, Iwata T, Tsunoda K; JEGC study group　(Murakami A). Genetic Spectrum of EYS-associated Retinal Disease in a Large Japanese Cohort: Identification of Disease-associated Variants with Relatively High Allele Frequency. Sci Rep. 2020; 10(1): 5497. doi: 10.1038/s41598-020-62119-3.（IF: 3.998）
  14. Fujinami-Yokokawa Y, Fujinami K, Kuniyoshi K, Hayashi T, Ueno S, Mizota A, Shinoda K, Arno G, Pontikos N, Yang L, Liu X, Sakuramoto H, Katagiri S, Mizobuchi K, Kominami T, Terasaki H, Nakamura N, Kameya S, Yoshitake K, Miyake Y, Kurihara T, Tsubota K, Miyata H, Iwata T, Tsunoda K; Japan Eye Genetics Consortium　(Murakami A).　 Clinical and Genetic Characteristics of 18 Patients from 13 Japanese Families with CRX-associated retinal disorder: Identification of Genotype-phenotype Association. Sci Rep. 2020; 10(1): 9531. doi: 10.1038/ s41598-020-65737-z（IF: 3.998）
  15. Hayashi T, Kameya S, Mizobuchi K, Kubota D, Kikuchi S, Yoshitake K, Mizota A, Murakami A, Iwata T, Nakano T: Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families. Sci Rep. 2020; 10(1): 15883. doi: 10.1038/s41598-020-72623-1.（IF: 3.998）
  16. Hirosawa K, Inomata T, Sung J, Nakamura M, Okumura Y, Midorikawa-Inomata A, Miura M, Fujio K, Akasaki Y, Fujimoto K, Zhu J, Eguchi A, Nagino K, Kuwahara M, Shokirova H, Yanagawa A, Murakami A. Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease.Sci Rep. 2020; 10(1): 18106. doi: 10.1038/s41598-020-75193-4. （IF: 3.998）
  17. Nojiri S, Itoh H, Kasai T, Fujibayashi K, Saito T, Hiratsuka Y, Okuzawa A, Naito T, Yokoyama K, Daida H: Comorbidity status in hospitalized elderly in Japan: Analysis from National Database of Health Insurance Claims and Specific Health Checkups. Sci Rep. 2019 Dec 27; 9(1): 20237. doi:10.1038/s41598-019-56534-4. （IF: 3.998）
  18. Hiratsuka Y, Yokoyama T, Yamada M: Higher participation rate for specific health checkups concerning simultaneous ophthalmic checkups. J Epidemiol. 2020 doi: 10.2188/jea.JE20200052. Online ahead of print. （IF: 3.691）
  19. Yoshida Y, Hiratsuka Y, Kawachi I, Murakami A, Kondo K, Aida J: Association between visual status and social participation in older Japanese: The JAGES cross-sectional study. Soc Sci Med. 2020; 253: 12959. doi: 10.1016/j.socscimed.2020.112959. Epub 2020 Apr 1.（IF: 3.616）
  20. Iwagawa T, Aihara Y, Umutoni D, Baba Y, Murakami A, Miyado K, Watanabe S: Cd9 Protects Photoreceptors from Injury and Potentiates Edn2 Expression. Invest Ophthalmol Vis Sci. 2020; 61(3): 7. doi: 10.1167/iovs.61.3.7.（IF: 3.470）
  21. Igarashi A, Aida J, Yamamoto T, Hiratsuka Y, Kondo K, Osaka K. Associations Between Vision, Hearing, and Tooth Loss and Social Interactions: The JAGES Cross-Sectional Study. J Epidemiol Community Health. 2020 ; jech-2020-214545. （IF: 3.342）
  22. Kawashima M, Yamada M, Shigeyasu C, Suwaki K, Uchino M, Hiratsuka Y, Yokoi N, Tsubota K, For The Decs-J FTD. Association of Systemic Comorbidities with Dry Eye Disease. J Clin Med. 2020; 9(7): 2040. doi: 10.3390/jcm9072040. （IF: 3.303）
  23. Unno H, Arae K, Matsuda A, Ikutani M, Tamari M, Motomura K, Toyama S, Suto H, Okumura K, Matsuda A, Morita H, Sudo K, Saito H, Matsumoto K, Nakae S. Critical role of IL-33, but not IL-25 or TSLP, in silica crystal-mediated exacerbation of allergic airway eosinophilia. Biochem Biophys Res Commun. 2020; 533(3): 493-500. doi: 10.1016/j.bbrc.2020.09.046. Epub 2020 Sep 22.（IF: 2.985）
  24. Nishiguchi KM, Kunikata H, Fujita K, Hashimoto K, Koyanagi Y, Akiyama M, Ikeda Y, Momozawa Y, Sonoda KH, Murakami A, Wada Y, Nakazawa T: Association of CRX genotypes and retinal phenotypes confounded by variable expressivity and electronegative electroretinogram. Clin Exp Ophthalmol. 2020; 48(5): 644-657. doi: 10.1111/ceo.13743, Epub 2020 Mar 17.（IF: 2.832）
  25. Fujimoto K, Inomata T, Okumura Y, Iwata N, Fujio K, Eguchi A, Nagino K, Shokirova H, Karasawa M, Murakami A: Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography. PLoS One. 2020; 15(2): e0228567. doi: 10.1371/journal.pone.0228567, eCollection 2020.（IF: 2.740）
  26. Sakanishi Y, Tamaki K, Mashimo K, Sakuma T, Ebihara N：Relationship between recurrence of macular edema due to branch retinal vein occlusion and changes in choroidal thickness. Ophthalmic Res. 2020 Oct 16. doi: 10.1159/000512357. Online ahead of print.（IF: 2.624）
  27. Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Okumura Y, Fujimoto K, Iwata N, Eguchi A, Shokirova H, Miura M, Fujio K, Nagino K, Nojiri S, Murakami A: Comparing the Japanese Version of the Ocular Surface Disease Index and Dry Eye-Related Quality-of-Life Score for Dry Eye Symptom Assessment. Diagnostics(Basel). 2020; 10(4): 203. doi:　 10.3390/diagnostics　10040203. （IF: 2.489）
  28. Shigeyasu C, Yamada M, Yokoi N, Kawashima M, Suwaki K, Uchino M, Hiratsuka Y, Tsubota K. Characteristics and Utility of Fluorescein Breakup Patterns among Dry Eyes in Clinic-Based Settings. Diagnostics(Basel). 2020; 10(9): 711. doi: 10.3390/diagnostics10090711. （IF: 2.489）
  29. Inomata T, Sung J, Nakamura M, Iwagami M, Okumura Y, Iwata N, Midorikawa- Inomata A, Fujimoto K, Eguchi A, Nagino K, Fujio K, Miura M, Shokirova H, Murakami A: Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease. Cornea. 2020 Oct 13. doi: 10. 1097/ICO.0000000000002500. Epub ahead of print. PMID: 33055549. （IF: 2.215）
  30. Kasuga T, Asaoka S, Asada Y, Iwamoto S, Hirakata T, Honda R, Ohta T, Matsuda A: Proline-assisted Tube Insertion Through Sulcus in Ahmed Valve. J Glaucoma. 2020; 29(9): E106-E107. doi: 10.1097/IJG.0000000000001602. （IF: 1.992）
  31. Asaoka S, Kasuga T, Matsunaga T, Hayashi Y, Asada Y, Iwamoto S, Hirakata T, Honda R, Obazawa H, Sasaki H, Ohta T, Matsuda A. Operative complications of glaucoma drainage implant tube insertion through the sulcus for pseudophakic eye. J Glaucoma, in press. （IF: 1.992）
  32. Kabashima K, Murakami A, Ebihara N: Effects of Benzalkonium Chloride and Preservative-Free Composition on the Corneal Epithelium Cells. J Ocul Pharmacol Ther. 2020; 36(9): 672-678. doi: 10.1089/jop.2019.0165, Online ahead of print.（IF: 1.925）
  33. Tamaki Y, Hiratsuka Y, Kumakawa T: Risk factors for dementia incidence based on previous results of the Specific Health Checkups in Japan. Healthcare. 2020; 8(4): 491. doi: 10.3390/ healthcare 8040491. （IF: 1.916）
  34. Sakanishi Y, Yasuda K, Morita S, Mashimo K, Tamaki K, Sakuma T, Ebihara N：Twenty-four-month results of intravitreal aflibercept for macular edema due to branch retinal vein occlusion. Jpn J Ophthalmol. 2020 Nov 12. doi: 10.1007/s10384-020-00785-6. Online ahead of print. （IF: 1.725）
  35. Hirakata T, Fujinami K, Saito W, Kanda A, Hirakata A, Ishida S, Murakami A, Tsunoda K, Miyake Y. Acute unilateral inner retinal dysfunction with photophobia: importance of electrodiagnosis. Jpn J Ophthalmol. 2020 Nov. （IF: 1.725）
  36. Mashimo K, Usui-Ouchi A, Ito Y, Wakasa-Arai R, Yokoi N, Kawasaki S, Murakami A, Matsuda A, Ebihara N. Role of Oncostatin M in the Pathogenesis of Vernal Keratoconjunctivitis: Focus on tissue remodeling. Jpn J Ophthalmol. in press （IF: 1.725）
  37. Eguchi A, Inomata T, Nakamura M, Ken Nagino K, Iwagami M, Sung J, Midorikawa-Inomata A, Okumura Y, Fujio K, Fujimoto K, Miura M, Akasaki Y, Shokirova H, Hirosawa K, Kuwahara M, Jun Zhu J, Dana R, Murakami A, and Kobayashi H. Heterogeneity of Eye Drop Use among Symptomatic Dry Eye Individuals in Japan: Large-scale Crowdsourced Research Using DryEyeRhythm Application. Jpn J Ophthalmol, 2020, in press. （IF: 1.725）
  38. Miyazaki D, Shimizu D, Fukushima A, Ebihara N, Uchio E, Shoji J, Namba K, Inoue Y, Ohashi Y, Okamoto S, Takamura E, Fujishima H：Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular disease. Jpn J Ophthalmol, 2020;64(6):568-576. （IF: 1.725）
  39. Matsuzawa M, Sakanishi Y, Ebihara N: Seasonal variation in the occurrence of retinal vein occlusion: a 4-year cross-sectional study. BMC Ophthalmol. 2020; 20(1): 265. doi: 10.1186/s12886-020-01534-6. （IF: 1.413）
  40. Koiwa C, Nakatani S, Inomata T, Yamaguchi M, Iwamoto S, Murakami A: Multiple excimer laser phototherapeutic keratectomies for Avellino corneal dystrophy: a case report. Int J Ophthalmol. 2020　;13(5): 841-844. doi: 10.18240/ijo.2020.05.22, eCollection 2020. （IF: 1.330）
  41. Ono K, Sakemi F, Marumoto T: Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma. Int Ophthalmol. 2020 Oct20: doi: 10.1007/s10792-020-01615-x.(IF: 1.314)
  42. Toshida H: Topographical Central Island-Like Pattern After 24 Hrs of Continuous　 Intraocular Pressure Monitoring with a Contact Lens Sensor., Int Med Case Rep. 2020; 13: 19-26. doi: 10.2147/IMCRJ.S232659. eCollection 2020.
  43. Watanabe S, Hamanaka T, Sakurai T, Kobayashi K, Ishida N, Ebihara N：Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis. Int Ophthalmol. 2020 Oct 14. doi: 10.1007/s10792-020-01601-3. Online ahead of print.
To Page Top

2019

【Original Articles】
  1. Matsuda A, Asada Y, Suita N, Iwamoto S, Hirakata T, Yokoi N, Ohkawa Y, Okada Y, Yokomizo T, Ebihara N: Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing. J Allergy Clin Immunol, 2019; 143(4): 1610-1614.e6. doi: 10.1016/j.jaci.2018.11.007. Epub 2018 Nov 22 (IF:14.110)
  2. Takamori A, Izawa K, Kaitani A, Ando T, Okamoto Y, Maehara A, Tanabe A, Nagamine M, Yamada H, Uchida S, Uchida K, Isobe M, Hatayama T, Watanabe D, Ando T, Ide T, Matsuzawa M, Maeda K, Nakano N, Tamura N, Ikeda K, Ebihara N, et al: Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation. J Allergy Clin Immunol, 2019; 143(3): 1231-1235 (IF:14.110)
  3. Usui-Ouchi A, Friedlander M: Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better. J Clin Invest, 2019; 129(8): 3032-3034 (IF: 12.282)
  4. Nikopoulos K, Cisarova K, Quinodoz M, Koskiniemi-Kuendig H, Miyake N, Farinelli P, Rehman AU, Khan MI, Prunotto A, Akiyama M, Kamatani Y, Terao C, Miya F, Ikeda Y, Ueno S, Fuse N, Murakami A, Wada Y, Terasaki H, Sonoda KH, Ishibashi T, Kubo M, Cremers FPM, Kutalik Z, Matsumoto N, Nishiguchi KM, Nakazawa T, Rivolta C: A frequent variant in the Japanese population determines quasi-Mendelian inheritance of rare retinal ciliopathy. Nat Commun, 2019; 10(1): 2884. doi: 10.1038/s41467-019-10746-4 (IF: 11.878)
  5. Inomata T, Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm. Ophthalmology 2019; 126(5): 766-768. doi: 10.1016/j.ophtha.2018.12.013. Epub 2018 Dec 11 (IF: 7.732)
  6. Nishiguchi KM, Ikeda Y, Fujita K, Kunikata H, Akiho M, Hashimoto K, Hosono K, Kurata K, Koyanagi Y, Akiyama M, Suzuki T, Kawasaki R, Wada Y, Hotta Y, Sonoda KH, Murakami A, Nakazawa M, Nakazawa T, Abe T: Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study. Ophthalmology, 2019; 126(11): 1557-1566. doi: 10.1016/j.ophtha.2019.05.027 (IF: 7.732)
  7. Fukuda K, Ebihara N, Kishimoto T, Fukushima A: Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis. J Allergy Clin Immunol Pract, 2019 Oct 31. pii: S2213-2198(19)30900-6. doi: 10.1016/j.jaip.2019.10.011. [Epub ahead of print] (IF: 7.550)
  8. Izawa K, Kaitani A, Ando T, Maehara A, Nagamine M, Yamada H, Ando T, Ide T, Matsuzawa M, Okamoto Y, Yin E, Fukase S, Wang H, Kamei A, Uchida S, Keiko M, Nakano N, Uchida K, Tamura N, Ikeda K, Ebihara N, Shimizu T, Voehringer D, Roers A, Ogawa H, Okumura K, Kitaura J：Differential lipid recognition by mouse versus human CD300f, inhibiting passive cutaneous anaphylaxis, depends on a single amino acid substitution in its immunoglobulin-like domain. J Invest Dermatol; 2019 Aug 30. pii: S0022-202X(19)33204-X. doi: 10.1016/j.jid.2019.08.439. [Epub ahead of print] (IF: 6.290)
  9. Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmology, 2019, Nov 27. doi: 10.1001/jamaophthalmol. 2019.4815. [Epub ahead of print]. (IF: 6.167)
  10. Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, Inai C, Iwasaki Y, Kumano M, Murakami Y, Omodaka K, Abe T, Komori S, Gao D, Hirakata T, Kurata K, Hosono K, Ueno S, Hotta Y, Murakami A, Terasaki H, Wada Y, Nakazawa T, Ishibashi T, Ikeda Y, Kubo M, Sonoda KH: Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet, 2019; 56(10): 662-670 (IF: 5.899)
  11. Hirakata T, Lee HC, Ohba M, Saeki K, Okuno T, Murakami A, Matsuda A, Yokomizo T. Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses. FASEB J, 2019; 33(3): 3392-3403. doi: 10.1096/fj.201801805R. Epub 2018 Nov 1. (IF: 5.391)
  12. Inagaki K, Hamada M, Ohkoshi K: Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor fordiabetic macular oedema. Sci Rep, 2019; 9　(1) : 7585 (IF: 4.011)
  13. Miyazaki D, Fukagawa K, Fukushima , Fujishima H, Uchio E, Ebihara N, Shoji J, Takamura E, Namba K, Ohashi Y, Okamoto S, Satake Y, Ohtsu H, Shimizu Y, Inoue Y：Air pollution significantly associated with severe ocular allergic inflammatory diseases Sci Rep, in press (IF: 4.011)
  14. Asada Y, Okano M, Ishida W, Iwamoto S, Fukuda K, Hirakata T, Tada N, Fukushima A, Ebihara N, Kudo A, Matsuda A: Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis. Allergol Int, 2019; 68(2): 233-239. doi: 10.1016/j.alit.2018.09.007. Epub 2018 Nov 9 (IF: 3.965)
  15. Honda S, Namekata K, Kimura A, Guo X, Harada C, Murakami A, Matsuda A, Harada: Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma. Invest Ophthalmol Vis Sci, 2019; 60(12): 3696-3707. doi: 10.1167/iovs.19-27145 (IF: 3.812)
  16. Okumura Y, Inomata T, Iwagami M, Eguchi A, Mizuno J, Shiang T, Kawasaki S, Shimada A, Inada E, Amano A, Murakami A: Shortened cataract surgery by standardisation of the perioperative protocol according to the Joint Commission International accreditation: a retrospective observational study. BMJ Open, 2019; 9(6): e028656. doi: 10.1136/bmjopen-2018-028656 (IF: 2.376)
  17. Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi1 H: Reliability and Validity of the Japanese Version of the Ocular Surface Disease Index for Dry Eye Disease. BMJ Open, 2019; 9(11): e033940. doi: 10.1136/bmjopen-2019-033940 (IF: 2.376)
  18. Okumura Y, Inomata T, Miyamoto S, Nakatani S, Hiratsuka Y, Yamaguchi M, Iwamoto S, Murakami A: Donor characteristics and risk factors for methicillin-resistant Staphylococcus aureus contamination in storage medium for corneal transplantation: A 10-year retrospective study. Transpl Infect Dis, 2019; 21(4): e13123. doi: 10.1111/tid.13123. Epub 2019 Jun 18. (IF: 2.112)
  19. Honda R, Kasuga T, Murakami A, Matsuda A: Effects of the Numbers and the Shapes of Venting Slits on Intraocular Pressure after Baerveldt Glaucoma Drainage Implant. Curr Eye Res, 2019; 44(8): 921-924. doi: 10.1080/02713683.2019.1597892. Epub 2019 Mar 28 (IF: 1.672)
  20. Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S：Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis. Curr Eye Res, 2019;44(7):796-805 (IF: 1.672)
  21. Miyagawa Y, Murakami A, Ebihara N.：The proteolytic effect of mast cell tryptase to eotaxin-1/CCL11・eotaxin-2/CCL24 and eotaxin-3/CCL26 produced by conjunctival fibroblasts. Jpn J Ophthalmol, 2019; 63(2): 215-220 (IF: 1.653)
  22. Nishino T, Kobayashi A, Mori N, Masaki T, Yokogawa H, Fujiki K, Yanagawa A, Murakami A, Sugiyama K: In vivo histology and p.L132V mutation in KRT12 gene in Japanese patients with Meesmann corneal dystrophy. Jpn J Ophthalmol, 2019; 63(1): 46-55. doi: 10.1007/s10384-018- 00643-6 (IF: 1.653)
  23. Itoh H, Saito T, Nojiri S, Hiratsuka Y, Yokoyama K: National burden of the pharmaceutical cost of wet compresses and its cost predictors: Nationwide cross-sectional study in Japan. Health Economics Review, 2019; 9(1): 20, https://doi.org/10.1186/s13561-019-0238-62019 (IF: 1.374)
  24. Sadamatsu Y, Hiratsuka Y, Michihata N, Jo T, Matsui H, Murakami A, Fushimi K, Yasunaga H. Activity of daily living improvement after cataract surgery for patients in nursing care facilities. Annals of Clinical Epidemiology, 2019; 1(3): 80-85
  25. Tamaki Y, Okamoto E, Hiratsuka Y, Kumakawa T. Influence of Specific Health Guidance on the Consultation Rate of Metabolic-Related Diseases. Advances in Public Health, Article ID 9735127, Volume 2019, 2019.
  26. Muto T, Nishimura T, Sakamoto M, Inomata T, Machida S. Identification of eyes at risk of acute primary angle-closure in elderly Japanese patients. Clin Ophthalmol, 2019; 13: 859-868
  27. Sakuma T, Watanabe S, Ouchi A, Sakanishi Y, Mizota A, Ebihara N：Three Cases of Creutzfeldt-Jakob Disease with Visual Disturbances as Initial Manifestation. Case Rep Ophthalmol, 2019; 10(3): 349-356
  28. Aung MN, Yuasa M, Moolphate S, Lorga T, Yokokawa H, Fukuda H, Kitajima T, Tanimura S, Hiratsuka Y, Ono K, Thinuan P, Minematsu K, Deerojanawong J, Suya Y, Marui E. Effectiveness of a new multi-component smoking cessation service package for patients with hypertension and diabetes in northern Thailand: a randomized controlled trial (ESCAPE study). Subst Abuse Treat Prev Policy, 2019 Feb 22; 14(1): 10
To Page Top

2018

【Original Articles】
  1. Morimoto Y, Hirahara K, Kiuchi M, Wada T, Ichikawa T, Kanno T, Okano M, Kokubo K, Onodera A, Sakurai D, Okamoto Y, Nakayama T：Amphiregulin-Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis．Immunity, 2018; 49(1): 134-150 (IF: 19.734)
  2. Suto H, Nambu A, Morita H, Yamaguchi S, Numata T, Yoshizaki T, Shimura E, Arae K, Asada Y, Motomura K, Kaneko M, Abe T, Matsuda A, Iwakura Y, Okumura K, Saito H, Matsumoto K, Sudo K, Nakae S: IL-25 enhances Th17 cell-mediated contact dermatitis by promoting IL-1b production by dermal dendritic cells. J Allergy Clin Immunol, 2018; 142: 1500-1509 (IF: 13.258)
  3. Vu CHV, Kawashima M, Yamada M, Suwaki K, Uchino M, Shigeyasu C, Hiratsuka Y, Yokoi N, Tsubota K: Dry Eye Cross-Sectional Study in Japan Study Group. Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye. Ophthalmology, 2018; 125(8): 1181-1188 (IF: 7.479)
  4. Kuribayashi H, Baba Y, Iwagawa T, Arai E, Murakami A, Watanabe S: Roles of Nmnat1 in the survival of retinal progenitors through the regulation of pro-apoptotic gene expression via histone acetylation. Cell Death Dis 2018, ; 9(9):891. doi: 10.1038/s41419-018-0907-0. (IF: 5.638)
  5. Tan X, Chen Y, Foulsham W, Amouzegar A, Inomata T, Liu Y, Chauhan SK, Dana R: The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf, 2018; 16(4): 470-477 (IF: 5.53)
  6. Inomata T, Iwagami M, Hiratsuka Y, Fujimoto K, Okumura Y, Shiang T, Murakami A: Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease. Sci Rep, 2018; 8(1): 13443. doi: 10.1038/s41598-018-31814-7 (IF: 4.122)
  7. Inomata T, Shiang T, Iwagami M, Sakemi F, Fujimoto K, Okumura Y, Ohno M, Murakami A: Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. Sci Rep, 2018; 8(1): 1918 (IF: 4.122)
  8. Inoue S, Kawashima M, Hiratsuka Y, Nakano T, Tamura H, Ono K, Murakami A, Tsubota K, Yamada M: Assessment of physical inactivity and locomotor dysfunction in adults with visual impairment. Sci Rep, 2018; 8(1): 12032. doi: 10.1038/s41598-018-30599-z. (IF: 4.122)
  9. Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T, Bluestone JA, Dana R: Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep, 2018; 8(1): 7059 (IF: 4.122)
  10. Hiraishi Y, Yamaguchi S, Yoshizaki T, Nambu A, Shimura E, Takamori A, Narushima S, Nakanishi W, Asada Y, Numata T, Suzukawa M, Yamauchi Y, Matsuda A, Arae K, Morita H, Hoshino T, Suto H, Okumura K, Matsumoto K, Saito H, Sudo K, Iikura M, Nagase T, Nakae S: IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation. Sci Rep, 2018; 8(1), 18052. doi: 10. 1038/s41598-018-36440-x. (IF: 4.122)
  11. Matsuno T, Toyoshima S, Sakamoto-Sasaki T, Kashiwakura J, Matsuda A, Watanabe Y, Azuma H, Kawana K, Yamamoto T, Okayama Y: Characterization of human decidual mast cells and establishment of a culture system. Allergol Int, 2018, 67S: S18-S24. doi: 10. 1016/j.alit. 2018. 05. 001. (IF: 4.045)
  12. Kawamura Y, Suga A, Fujimaki T, Yoshitake K, Tsunoda K, Murakami A, Iwata T: LRRTM4-C538Y novel gene mutation is associated with hereditary macular degeneration with novel dysfunction of ON-type bipolar cells. J Hum Genet, 2018; 63(8): 893-900. doi: 10.1038/s10038-018-0465-4. Epub 2018 May 14. (IF: 2.942)
  13. Inomata T, Mizuno J, Iwagami M, Kawasaki S, Shimada A, Inada E, Shiang T, Amano A: The impact of Joint Commission International accreditation on time periods in the operating room: A retrospective observational study. PLoS ONE, 2018 13(9): e0204301 (IF: 2.766)
  14. Niihata K, Fukuma S, Hiratsuka Y, Ono K, Yamada M, Sekiguchi M, Otani K, Kikuchi S, Konno S, Fukuhara S: Association between vision-specific quality of life and falls in community-dwelling elderly people: LOHAS. PLoS ONE, 2018 Apr 24; 13(4):e0195806. doi: 10.1371/journal.pone. 0195806. eCollection 2018 (IF: 2.766)
  15. Ohta T, Ichikawa K, Matsuzaki Y, Toshida H, Murakami A: L-pocket scleral incision. J Cataract Refract Surg, (in press) (IF: 2.68)
  16. Toshida H, Suto C: Preganglionic parasympathetic denervation rabbit, model for innervation studies. Cornea, 2018; 37(Suppl 1); s106-s112 (IF; 2.464)
  17. Inomata T, Hua J, Nakao T, Shiang T, Chiang H, Amouzegar A, Dana R: Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. Cornea, 2018 Jan;37(1):95-101. doi: 10.1097/ICO.0000000000001400 (IF:2.464)
  18. Shigeyasu C, Yamada M, Kawashima M, Suwaki K, Uchino M, Hiratsuka Y, Yokoi N, Tsubota K: DECS-J study group. Quality of life measures and health utility values among dry eye subgroups. Health Qual Life Outcomes, 2018; 16(1): 170. doi: 10.1186/s12955-018-0999-3 (IF; 2.278)
  19. Nomura Y, Toida H , Fukui C , Kai S , Nakaoka R , Kato R , Uematsu M , Ono K , Kanai A , Haishima Y: Evaluation of Pigment Distribution and Depth Analysis Methods for Decorative Soft Contact Lenses. Eye & Contact lens, 2018; 44: S105-S112(IF: 1.813)
  20. Iwatake A, Murakami A, Ebihara N：The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells．Jpn J Ophthalmol, 2018; 62(1): 92-100 (IF: 1.775)
  21. Hamada M, Ohkoshi K, Inagaki K, Ebihara N, Murakami A: Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images．Jpn J Ophthalmol, 2018; 62(2): 168-175 (IF: 1.775)
  22. Hamada M, Ohkoshi K, Inagaki K, Ebihara N, Murakami A: Correction to: Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images. Jpn J Ophthalmol,2018; 62(2): 176-178 (IF: 1.775)
  23. Takei M, Obana A, Inomata T, Tanaka T, Shiang T, Bae Y, Takemura T, Murakami A: Fundus changes in type III membranoproliferative glomerulonephritis: a case report. BMC Ophthalmol, 2018; 18(1): 72, https://doi.org/10.1186/s12886-018-0738-x (IF: 1.77)
  24. Hamada M, Ohkoshi K, Inagaki K, Ebihara N, Murakami A.：Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema．J Ophthalmol, 2018; Jan 31;2018: 7465794 eCollection (IF: 1.68)
  25. Ichikawa K, Kambe T, Kurihara J, Hiratsuka Y, Murakami A: Visual Impairment Caused by an Intra-Orbital Dermoid Cyst in 9-Month-Old Infant, Ann Case Rep: ACRT-167, 2018. DOI: 10.29011/2574-7754/100067
  26. Miura-Karasawa, Toshida H, Ohta T, Murakami A: Papilloma and sebaceous gland hyperplasia of the lacrimal caruncle: a case report. Int Med Case Rep J, 2018 Apr 27; 11: 91-95. doi: 10.2147/IMCRJ.S162528. eCollection 2018.
  27. Tamaki Y, Hiratsuka Y, Kumakawa T, Miura H: Relationship between the Necessary Support Level for Oral Hygiene and Performance of Physical, Daily Activity, and Cognitive Functions. International Journal of Dentistry, Vol 2018, Article ID 1542713, https://doi.org/10.1155/ 2018/1542713
  28. Qi H, Chen Y, Inomata T, Amouzegar A, Dana R: IL-10-Producing Th17 Cells: A Potentially Regulatory Cell Population in Dry Eye Disease. Journal of Immunology and Immunotherapy, 2018; 2(1): 1-5
  29. Ogawa M, Inomata T, Shiang T, Tsubota K, Murakami A: Method for selective quantification of immune and inflammatory cells in the cornea using flow cytometry. J Biol Methods, 2018; 5(4): e102. doi: 10.14440/jbm.2018.237
To Page Top
 Introduction   Staff   Research   Education   Achievements   Recruitment   Links
 Japanese     Index
To Page Top